Clinical Trial Update: Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Prochymal infusion with corticosteroids for newly diagnosed acute graft-versus-host disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• PROCHYMAL (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Graft Versus Host Disease | Phase 3 | Status: COMPLETED